Comparison of Apnea Tolerance in Two Positions of Patients With BMI 30-40
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03056820 |
Recruitment Status :
Completed
First Posted : February 17, 2017
Last Update Posted : February 17, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
General Surgery | Other: 25° head-up position Other: 55° head-up position | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 74 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Masking Description: | The person measuring and recording the study data will be blinded. |
Primary Purpose: | Health Services Research |
Official Title: | Comparison of Apnea Tolerance in Two Positions of Patients With Body Mass Index (BMI) 30-40 |
Actual Study Start Date : | May 2010 |
Actual Primary Completion Date : | March 2011 |
Actual Study Completion Date : | March 2011 |
Arm | Intervention/treatment |
---|---|
Active Comparator: A - 25° head-up position
Participants will be positioned at 25° angle for procedure.
|
Other: 25° head-up position
Participant will be positioned at 25° angle for procedure. |
Active Comparator: B - 55° head-up position
Participants will be positioned at 55° angle for procedure.
|
Other: 55° head-up position
Participant will be positioned at 55° angle for procedure. |
- Tolerable Apnea Time (TAT) [ Time Frame: Time between start of induction of general anesthesia (SpO2 100%) to decline of SpO2 94%, up to eight minutes ]Measure of the TAT between groups to determine if the TAT is a function of the participant's position.
- Length of time to intubation (TTI) [ Time Frame: Time between start of the tracheal intubation procedure to completion of tracheal intubation, up to 2 minutes ]
- Peripheral arterial hemoglobin oxygen saturation (SpO2) trough [ Time Frame: Time until SpO2 decreased to 92%, up to 8 minutes ]Measure of the rebound SpO2. It is the lowest SpO2 reading reached subsequent to start of mechanical ventilation at the SpO2 value of 94% and it represents final completion of SpO2 decline.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) physical status I-III
- Body Mass Index (BMI) of 30-40
- Scheduled for an elective surgery that requires tracheal intubation
Exclusion Criteria:
- Patients with abnormalities of the upper airway that require awake tracheal intubation
- Asthma
- Chronic obstructive pulmonary disease
- Congestive heart failure
- Pregnant patients

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03056820
United States, Kansas | |
University of Kansas Medical Center | |
Kansas City, Kansas, United States, 66160 |
Principal Investigator: | Mirsad Dupanović, MD | University of Kansas Medical Center |
Responsible Party: | University of Kansas Medical Center |
ClinicalTrials.gov Identifier: | NCT03056820 |
Other Study ID Numbers: |
12197 |
First Posted: | February 17, 2017 Key Record Dates |
Last Update Posted: | February 17, 2017 |
Last Verified: | February 2017 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
tracheal intubation |